BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 15356133)

  • 41. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virus-induced activation of self-specific TCR alpha beta CD8 alpha alpha intraepithelial lymphocytes does not abolish their self-tolerance in the intestine.
    Saurer L; Seibold I; Rihs S; Vallan C; Dumrese T; Mueller C
    J Immunol; 2004 Apr; 172(7):4176-83. PubMed ID: 15034030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus.
    Munitic I; Kuka M; Allam A; Scoville JP; Ashwell JD
    J Immunol; 2013 Feb; 190(3):1169-79. PubMed ID: 23269247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice.
    de Lemos C; Christensen JE; Nansen A; Moos T; Lu B; Gerard C; Christensen JP; Thomsen AR
    J Immunol; 2005 Aug; 175(3):1767-75. PubMed ID: 16034118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel approach to visualize polyclonal virus-specific CD8 T cells in vivo.
    Zimmermann C; Pircher H
    J Immunol; 1999 May; 162(9):5178-82. PubMed ID: 10227990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses.
    Andreasen SO; Christensen JE; Marker O; Thomsen AR
    J Immunol; 2000 Apr; 164(7):3689-97. PubMed ID: 10725727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD40L expression by CD4
    Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
    Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
    Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
    J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes.
    Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB
    J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Origin and fate of lymphocytic choriomeningitis virus-specific CD8+ T cells coexpressing the inhibitory NK cell receptor Ly49G2.
    Peacock CD; Welsh RM
    J Immunol; 2004 Jul; 173(1):478-84. PubMed ID: 15210808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.
    Decman V; Laidlaw BJ; Dimenna LJ; Abdulla S; Mozdzanowska K; Erikson J; Ertl HC; Wherry EJ
    J Immunol; 2010 May; 184(9):5151-9. PubMed ID: 20368274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
    Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
    Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Kurt-Jones EA; Mandell L; Cerny A; Chan M; Golenbock DT; Finberg RW
    Eur J Immunol; 2005 Mar; 35(3):822-30. PubMed ID: 15724245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendritic Cells Are Dispensable for T Cell Priming and Control of Acute Lymphocytic Choriomeningitis Virus Infection.
    Hilpert C; Sitte S; Matthies A; Voehringer D
    J Immunol; 2016 Oct; 197(7):2780-6. PubMed ID: 27549169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin.
    Grujic M; Christensen JP; Sørensen MR; Abrink M; Pejler G; Thomsen AR
    J Immunol; 2008 Jul; 181(2):1043-51. PubMed ID: 18606656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homeostatic turnover of virus-specific memory CD8 T cells occurs stochastically and is independent of CD4 T cell help.
    Choo DK; Murali-Krishna K; Anita R; Ahmed R
    J Immunol; 2010 Sep; 185(6):3436-44. PubMed ID: 20733203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice.
    Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB
    J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection.
    Pallmer K; Barnstorf I; Baumann NS; Borsa M; Jonjic S; Oxenius A
    PLoS Pathog; 2019 Apr; 15(4):e1007725. PubMed ID: 30995287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.